Oppenheimer & Co. Inc. Acquires 5,689 Shares of The Clorox Company $CLX

Oppenheimer & Co. Inc. raised its holdings in The Clorox Company (NYSE:CLX) by 23.0% in the third quarter, Holdings Channel reports. The fund owned 30,400 shares of the company’s stock after acquiring an additional 5,689 shares during the period. Oppenheimer & Co. Inc.’s holdings in Clorox were worth $2,463,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of CLX. BlackRock Inc. acquired a new stake in shares of Clorox during the second quarter worth $958,640,000. Bank of America Corp DE acquired a new position in Clorox in the 2nd quarter valued at $179,780,000. Royal Bank of Canada grew its position in Clorox by 20.1% during the first quarter. Royal Bank of Canada now owns 1,418,204 shares of the company’s stock worth $146,969,000 after buying an additional 237,301 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in Clorox during the second quarter worth about $123,154,000. Finally, Confluence Investment Management LLC increased its stake in Clorox by 33.8% in the second quarter. Confluence Investment Management LLC now owns 1,247,644 shares of the company’s stock valued at $119,075,000 after acquiring an additional 315,069 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.

Clorox Stock Performance

NYSE:CLX opened at $88.01 on Friday. The company has a fifty day moving average of $88.61 and a 200-day moving average of $100.01. The firm has a market capitalization of $10.64 billion, a P/E ratio of 18.26, a P/E/G ratio of 2.97 and a beta of 0.59. The company has a quick ratio of 0.38, a current ratio of 0.66 and a debt-to-equity ratio of 15.80. The Clorox Company has a twelve month low of $79.12 and a twelve month high of $128.90.

Clorox (NYSE:CLX) last released its earnings results on Monday, August 3rd. The company reported $1.66 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.64 by $0.02. The company had revenue of $1.95 billion for the quarter, compared to the consensus estimate of $1.91 billion. Clorox had a net margin of 8.74% and a return on equity of 522.23%. Clorox’s quarterly revenue was down 2.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.87 EPS. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. As a group, sell-side analysts anticipate that The Clorox Company will post 5.66 EPS for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Wednesday, October 28th will be issued a dividend of $1.25 per share. The ex-dividend date is Wednesday, October 28th. This represents a $5.00 annualized dividend and a dividend yield of 5.7%. Clorox’s dividend payout ratio is currently 103.73%.

Key Headlines Impacting Clorox

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: New CEO appointed: Clorox named Fabian Garcia, a veteran consumer-products executive from Unilever, as CEO and chair effective January 5, 2027. His experience could help strengthen brand execution and support a turnaround after a comprehensive search. Matthew Shattock will resume his role as independent chair, while Linda Rendle is stepping down for health reasons. Clorox Appoints Fabian Garcia as CEO
• Positive Sentiment: Potential earnings support: Analysts expect fiscal first-quarter 2027 results to benefit from product innovation, brand investments and the contribution from GOJO, the hand-care business acquired by Clorox. A stronger-than-expected report could provide a near-term catalyst. Clorox’s Q1 Earnings Coming Up: Key Insights for Investors
• Neutral Sentiment: Valuation is being debated: Recent commentary suggests CLX may be fairly valued based on expected earnings, while the incoming CEO could make the stock appear inexpensive if he improves growth and profitability. Investors are likely to focus on guidance and the pace of recovery rather than valuation alone. Clorox Stock Looks About Right Based on Earnings
• Negative Sentiment: Profitability and dividend risks remain: Higher costs, cautious consumer spending and potential pressure on margins may limit the benefit from innovation and GOJO. Analysts also view the dividend as facing a more difficult test, making cash flow and management’s outlook key issues in the earnings release. Clorox: An Easy Quarter Ahead, But a Harder Test for the Dividend

Analyst Ratings Changes

CLX has been the subject of a number of research analyst reports. Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a research report on Tuesday, October 6th. Wells Fargo & Company cut their price objective on Clorox from $90.00 to $85.00 and set an “equal weight” rating on the stock in a research note on Monday, October 5th. Evercore set a $99.00 price target on shares of Clorox in a research report on Tuesday, August 4th. JPMorgan Chase & Co. decreased their price target on Clorox from $95.00 to $83.00 and set an “underweight” rating for the company in a report on Monday, October 19th. Finally, Wall Street Zen lowered Clorox from a “hold” rating to a “sell” rating in a research report on Saturday, October 3rd. Twelve investment analysts have rated the stock with a Hold rating and four have issued a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Reduce” and an average price target of $93.57.

Clorox Profile

The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.

Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt’s Bees personal care items.